Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DMRA compared with CBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
DMRA
Damora Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CBIO
Crescent Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DMRA
Damora Therapeutics, Inc.
vs
CBIO
Crescent Biopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DMRA, solid
CBIO, dashed
DMRA
Damora Therapeutics, Inc.
Change
23.56
▲
+7.78%
· post 23.56
Mkt cap
$1.5B
Revenue
—
CBIO
Crescent Biopharma, Inc.
Change
13.80
▲
+6.68%
· post 13.28
Closed
Nov 6 '26
Mkt cap
$502.9M
Revenue
$1M
Q1 FY26
vs
Compare
Closed
Nov 6 '26
DMRA
Damora Therapeutics, Inc.
vs
CBIO
Crescent Biopharma, Inc.
23.56
▲
+7.78%
post 23.56
Price
13.80
▲
+6.68%
post 13.28
$1.5B
Mkt cap
$502.9M
—
Revenue
$1M
Q1 FY26
Change
Change
DMRA
23.56
▲
+7.78%
vs
CBIO
13.80
▲
+6.68%
Closed
Nov 6 '26